Narayana Hrudayalaya Ltd
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 35,027 Cr.
- Current Price ₹ 1,714
- High / Low ₹ 1,873 / 1,080
- Stock P/E 81.6
- Book Value ₹ 95.3
- Dividend Yield 0.23 %
- ROCE 22.7 %
- ROE 25.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 53.0% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 17.9%
Cons
- Stock is trading at 18.0 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
825 | 1,076 | 1,308 | 1,470 | 1,646 | 1,848 | 2,077 | 2,239 | 1,655 | 2,412 | 2,965 | 3,266 | 3,517 | |
738 | 960 | 1,182 | 1,295 | 1,427 | 1,664 | 1,881 | 1,971 | 1,676 | 2,146 | 2,471 | 2,656 | 2,865 | |
Operating Profit | 87 | 115 | 126 | 175 | 219 | 184 | 196 | 268 | -21 | 266 | 494 | 609 | 652 |
OPM % | 11% | 11% | 10% | 12% | 13% | 10% | 9% | 12% | -1% | 11% | 17% | 19% | 19% |
2 | 25 | 10 | 2 | 14 | 16 | 17 | 19 | 71 | 104 | 95 | 120 | 125 | |
Interest | 17 | 29 | 38 | 23 | 17 | 26 | 43 | 55 | 48 | 45 | 55 | 65 | 77 |
Depreciation | 44 | 55 | 64 | 67 | 68 | 78 | 91 | 128 | 123 | 119 | 139 | 161 | 168 |
Profit before tax | 28 | 56 | 34 | 86 | 147 | 95 | 79 | 104 | -121 | 206 | 395 | 503 | 533 |
Tax % | 35% | 36% | 38% | 34% | 35% | 39% | 37% | 35% | -35% | 35% | 33% | 16% | |
18 | 36 | 21 | 57 | 95 | 58 | 50 | 68 | -79 | 134 | 266 | 425 | 429 | |
EPS in Rs | 566.99 | 1,107.25 | 1.05 | 2.77 | 4.65 | 2.86 | 2.45 | 3.31 | -3.85 | 6.54 | 13.00 | 20.77 | 21.01 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 41% | 30% | 0% | 15% | 19% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 25% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 32% |
5 Years: | 53% |
3 Years: | 98% |
TTM: | 20% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 46% |
3 Years: | 40% |
1 Year: | 37% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 13% |
3 Years: | 20% |
Last Year: | 25% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.33 | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Reserves | 533 | 569 | 595 | 753 | 854 | 916 | 963 | 962 | 885 | 1,021 | 1,264 | 1,636 | 1,744 |
238 | 321 | 289 | 152 | 120 | 491 | 499 | 607 | 551 | 533 | 644 | 1,011 | 957 | |
156 | 237 | 216 | 274 | 309 | 383 | 410 | 449 | 462 | 528 | 664 | 645 | 805 | |
Total Liabilities | 927 | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 3,710 |
503 | 626 | 651 | 650 | 682 | 973 | 949 | 1,159 | 1,070 | 1,094 | 1,358 | 1,480 | 1,914 | |
CWIP | 44 | 12 | 9 | 13 | 52 | 30 | 56 | 3 | 5 | 23 | 32 | 34 | 37 |
Investments | 31 | 51 | 241 | 334 | 354 | 561 | 597 | 619 | 645 | 661 | 678 | 1,021 | 941 |
348 | 438 | 399 | 386 | 399 | 431 | 475 | 441 | 382 | 507 | 709 | 962 | 818 | |
Total Assets | 927 | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 3,710 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
45 | 164 | 61 | 177 | 218 | 196 | 208 | 286 | 123 | 246 | 516 | 542 | |
-122 | -172 | -192 | -130 | -162 | -446 | -137 | -129 | -12 | -117 | -621 | -761 | |
87 | 5 | 127 | -2 | -32 | 226 | -11 | -170 | -114 | -57 | 65 | 237 | |
Net Cash Flow | 9 | -3 | -4 | 46 | 25 | -24 | 61 | -12 | -3 | 72 | -40 | 19 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40 | 45 | 40 | 34 | 31 | 37 | 28 | 24 | 34 | 26 | 22 | 21 |
Inventory Days | 58 | 63 | 55 | 46 | 42 | 41 | 36 | 24 | 19 | 18 | 17 | 28 |
Days Payable | 121 | 206 | 136 | 142 | 161 | 179 | 165 | 171 | 237 | 177 | 211 | 192 |
Cash Conversion Cycle | -23 | -98 | -41 | -62 | -88 | -102 | -101 | -124 | -184 | -133 | -172 | -143 |
Working Capital Days | 11 | -12 | 6 | 3 | -1 | -5 | -15 | -23 | -34 | -23 | -27 | -23 |
ROCE % | 6% | 9% | 7% | 11% | 15% | 9% | 8% | 9% | -4% | 15% | 23% | 23% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - The management of the company will host a conference call to discuss the Company''s performance on Tuesday, May 27, 2025 at 03:00 p.m. IST
-
Board Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2025, Dividend And Fund Raising
16 May - Board meeting on May 23 to approve FY25 results, recommend dividend, and propose debt raise via private placement.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Revised
30 Apr - Rs.2.22 Cr GST penalty on COVID vaccination challenged; interim stay granted by Karnataka High Court.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
29 Apr - Rs. 2.22 Cr GST penalty on COVID vaccination services challenged; interim stay granted by Karnataka High Court.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14 Apr - Of schedule of investors meeting to be held on April 16, 2025
Annual reports
Concalls
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptNotesPPT
Hospital Portfolio[1][2]
- India: 19 owned/operated hospitals, 2 heart centers, 18 clinics, and dialysis centers.
- Cayman Islands: 1 hospital.
** - Total:** 40 healthcare facilities with 5,789 operational beds (including Cayman).